PMI Digital Series – May Webinars

While we can’t meet in person just now, the PMI are acutely aware of the need for regular industry updates, and a little motivation during these very difficult and challenging times.  Following on from our popular “Webinar Wednesdays” series which launched in April, we are continuing this channel into May as the restrictions continue.

For the month of May, we’ll have 3 webinars which will take place Wednesday mornings at 8am.  These webinars run from May 6th to May 20th inclusive. 

 There will be an opportunity to pose questions to the speakers in the live webinars, however if you are unable to make the live webinar, you also have the option watch at your leisure as each session is recorded.

Download the May webinar brochure here:

May webinar series – still to come: 

20th May – Danny McCoy, Chief Executive Officer with Ibec 

Danny has held the role of CEO with Ibec since 2009. Ibec is Ireland’s largest business representative organisation and the country’s largest lobbying group. It has 240 staff in seven locations and has 38 sectoral brands and substantial presence within the European Union through Ibec’s Brussels office.
Prior to joining Ibec, Danny was a senior economist at both the Economic and Social Research Institute (ESRI) and the Central Bank of Ireland in Dublin. He has held lecturing posts at Dublin City University, University College London, University of Oxford and Trinity College Dublin. He has been a consultant for the European Commission and the OECD. He has been a member of the Irish National Competitiveness Council, the National Economic and Social Council, the Commission on Taxation and the National Training Agency. He led a European Macroeconomic Forecasting Network for the European Commission of eleven national research institutes.
He currently is President of the Statistical and Social Inquiry Society of Ireland, Honorary Fellow of the Academy of Engineers, member of the Export Trade Council and the Executive Bureau of BusinessEurope.
His academic work in the early 1990s covered carbon taxation and Sustainable Development for which he received a ESR scholarship and the Barrington Medal for researchers under 30.

Topics: Danny will give an update from Ibec to cover the economic impact of Covid19 & support from government to both industries and individuals.  He’ll also give a view on current economy and predictions for next 6/12 months  and what can be done to improve the outlook.

May webinar series – recorded: 

13th May – Fionnuala King, Chief Pharmacist with Acute Hospitals Drug Management Programme

Fionnuala is the Chief Pharmacist for the Acute Hospitals Drug Management Programme.   She was previously business-lead for the implementation of the National Cancer Information System (NCIS), a national Electronic Patient Record for Medical Oncology and Haemato-Oncology which is being introduced in 26 sites nationally. Fionnuala has over 20 years of clinical experience in oncology and haematology and led the haem/onc pharmacy team in St. James Hospital prior to taking up her new role.  Fionnuala qualified as pharmacist at Robert Gordon University, completed post-graduate studies in Clinical Pharmacy at the University of London, a Masters in Leadership and Organisational Learning in Royal College of Surgeons Dublin and further post-graduate studies in Cancer Studies in Newcastle University. Her particular areas of interest are in Pharmacy Practice, Process Improvement and Medication Safety. Fionnuala has published her work in a number of journals and has taught at post-graduate level in TCD, UCC and RCPI and was awarded the Oncology Pharmacist of the Year award in 2013. 

Topics: Fionnuala will give a perspective on the impact of Covid19 from an acute hospital setting – both on patients suffering from the illness, and the management of patients with chronic illnesses. 

13th May – Prof Luke O’Neill, Immunologist with Trinity College Dublin 

 Luke holds the Chair of Biochemistry at Trinity College Dublin where he leads the Inflammation Research Group. He has a PhD in Pharmacology from the University of London and carried out Post-Doctoral research at Cambridge U.K. His research is in the area of the molecular basis to inflammation with a particular focus on innate immunity, Toll-like receptors, inflammasomes and metabolic reprogramming in macrophage activation. In 2019 he was named by Clarivates/Thompson Reuters as one of the world’s most influential scientists, being in the top 1% in Immunology. He has also recently been ranked by the journal PLoS Biology as Ireland’s leading scientist, based on the impact of his work. He is co-founder of spin-out companies Inflazome and Sitryx, which are developing new treatments for inflammatory diseases. He has won numerous awards for his research including the European Federation of Immunology Societies medal, the International Cytokine and Interferon Society Milstein Award, The Royal Dublin Society Boyle Medal for Scientific Excellence, The Royal Irish Academy Gold Medal for Life sciences. He was elected a Fellow of the Royal Society in 2016.

6th May – Gwynne Morley, General Manager with IQVIA

Gwynne is the General Manager of IQVIA Solutions and CSMS division of IQVIA.  She is former Director of Heart & Vascular, Diabetes & Emergency Department at the Mater Private Hospital and former Managing Director at Uniphar Retail Services division.  She has extensive experience and knowledge of the pharmaceutical industry, from the manufacturer to the patient. Previously she worked for United Drug Group (UDG) Healthcare for 13 years where she was a member of the Senior Executive team. During her tenure with UDG, she held a number of senior roles namely in pre-wholesale, consumer, homecare and quality. Prior to joining UDG, she held management positions within the Crowley Retail Pharmacy Chain and held a multifunctional role within the medical department of Zeneca Pharma, Ireland. Gwynne is a pharmacy graduate of Trinity College, Dublin.

Topics: Gwynne will give some insight into the data collected across Europe detailing the impact of Covid-19, how this is affecting both primary and secondary care, and the likely implications for the future.